0001209191-19-024577.txt : 20190415
0001209191-19-024577.hdr.sgml : 20190415
20190415161219
ACCESSION NUMBER: 0001209191-19-024577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190412
FILED AS OF DATE: 20190415
DATE AS OF CHANGE: 20190415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUBINO RICHARD J
CENTRAL INDEX KEY: 0001252014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 19748726
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-313-9650
MAIL ADDRESS:
STREET 1: 7020 KIT CREEK ROAD
STREET 2: SUITE 270
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-12
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001252014
RUBINO RICHARD J
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
0
1
0
0
Chief Financial Officer
Common Stock
2019-04-12
4
F
0
1549
41.89
D
323169
D
Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of performance-based restricted Common Stock.
/s/ John LaRocca, Attorney-in-Fact for Richard J. Rubino
2019-04-15